Journal of investigative medicine high impact case reports · 2026
Primary Lung Adenocarcinoma as a Second Neoplasm Following Chronic Lymphocytic Leukemia: A Case Report.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fernández-Trujillo Liliana, Sua Luz F, Muñoz-Manzano Juan P, Ibarra-Enriquez Ciro D, Bravo Juan C
Аннотация
Chronic lymphocytic leukemia (CLL) and its variant, small lymphocytic lymphoma (SLL), are common adult leukemias characterized by the accumulation of mature monoclonal B lymphocytes. CLL primarily involves peripheral blood, spleen, and lymph nodes, whereas SLL predominantly affects lymph nodes. Patients with CLL/SLL are at increased risk of developing second primary malignancies, including lung cancer, highlighting the need for ongoing surveillance. We report the case of an 83-year-old man with a history of CLL/SLL who developed pulmonary adenocarcinoma. He presented weight loss and constitutional symptoms; imaging revealed retroperitoneal and mesenteric lymph node conglomerates along with a lung lesion. Histopathology confirmed SLL in the lymph nodes and primary mucinous adenocarcinoma of the lung. Evidence shows a heightened risk of second primary neoplasms in CLL/SLL, particularly among patients exposed to alkylating agents. This case emphasizes the role of demographic and treatment-related factors-such as male sex, advanced age, smoking history, and therapeutic regimens-in secondary cancer development. Vigilant monitoring and a multidisciplinary approach tailored to individual risk are essential for early detection and optimal management in this population.